SIH Partners’s Amgen AMGN Stock Holding History

SIH Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,528	Closed	-$2.3M	–	328
2026 Q1	$2.3M	Buy	+6,528	New	+$2.33M	0.03%	135
2025 Q2	–	Sell	-42,844	Closed	-$13.3M	–	175
2025 Q1	$13.3M	Buy	+42,844	New	+$12.7M	0.45%	29

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SIH Partners's AMGN Position: Q2 2026 in Review

SIH Partners sold out of Amgen (AMGN) in Q2 2026, closing a stake of 6,528 shares — an estimated $2.3M sold.

SIH Partners first reported a position in AMGN in Q1 2025 and held it in 2 quarters. The position peaked at $13.3M in Q1 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

SIH Partners reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
SIH Partners sold 6,528 Amgen shares in Q2 2026, an estimated $2.3M.
SIH Partners first reported a position in Amgen in Q1 2025 and held it in 2 quarters.
SIH Partners's Amgen position peaked at $13.3M in Q1 2025.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SIH Partners's 13F filing for Q2 2026, filed 14 Aug 2026.